proven < provide < provided

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by provide

Number of relevant bibliographic references: 117.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000020 (2020)	S M Shen [République populaire de Chine]	[Study on issues for stomatological institutions responding to state public health emergencies].
000022 (2020)	Q. Zhou [République populaire de Chine] ; J. Xue [République populaire de Chine] ; L N Ma [République populaire de Chine] ; N X Tong [République populaire de Chine] ; C F Wang [République populaire de Chine] ; Q. Shi [République populaire de Chine] ; X Q Lu [République populaire de Chine] ; Y. Jiao [République populaire de Chine] ; X C Hu [République populaire de Chine]	[Strategy of nursing care on the face skin injuries caused by wearing medical-grade protective equipment].
000045 (2020)	Z. Zhao [République populaire de Chine] ; H. Bai ; J C Duan ; J. Wang	[Individualized treatment recommendations for lung cancer patients at different stages of treatment during the outbreak of 2019 novel coronavirus disease epidemic].
000048 (2020)		[Health protection guideline of mobile cabin hospitals during Novel Coronavirus Pneumonia (NPC) outbreak].
000114 (2020)	Daniel B. Jernigan	Update: Public Health Response to the Coronavirus Disease 2019 Outbreak - United States, February 24, 2020.
000155 (2020)	Noah C. Peeri [États-Unis] ; Nistha Shrestha [États-Unis] ; Md Siddikur Rahman [Bangladesh] ; Rafdzah Zaki [Malaisie] ; Zhengqi Tan [États-Unis] ; Saana Bibi [Pakistan] ; Mahdi Baghbanzadeh [Iran] ; Nasrin Aghamohammadi [Malaisie] ; Wenyi Zhang [République populaire de Chine] ; Ubydul Haque [États-Unis]	The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?
000184 (2020)	Julia Smith ; Nathan Sears [Canada] ; Ben Taylor [Canada] ; Madeline Johnson [Canada]	Serious games for serious crises: reflections from an infectious disease outbreak matrix game
000191 (2020)	Markus Hoffmann [Allemagne] ; Hannah Kleine-Weber [Allemagne] ; Simon Schroeder [Allemagne] ; Nadine Krüger [Allemagne] ; Tanja Herrler [Allemagne] ; Sandra Erichsen [Autriche] ; Tobias S. Schiergens [Allemagne] ; Georg Herrler [Allemagne] ; Nai-Huei Wu [Allemagne] ; Andreas Nitsche [Allemagne] ; Marcel A. Müller [Russie] ; Christian Drosten [Allemagne] ; Stefan Pöhlmann [Allemagne]	SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
000199 (2020)	Fang Jiang [République populaire de Chine] ; Liehua Deng [République populaire de Chine] ; Liangqing Zhang [République populaire de Chine] ; Yin Cai [République populaire de Chine] ; Chi Wai Cheung [République populaire de Chine] ; Zhengyuan Xia [République populaire de Chine]	Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19).
000210 (2020)	Sung-Mok Jung [Japon] ; Andrei R. Akhmetzhanov [Japon] ; Katsuma Hayashi [Japon] ; Natalie M. Linton [Japon] ; Yichi Yang [Japon] ; Baoyin Yuan [Japon] ; Tetsuro Kobayashi [Japon] ; Ryo Kinoshita [Japon] ; Hiroshi Nishiura [Japon]	Real-Time Estimation of the Risk of Death from Novel Coronavirus (COVID-19) Infection: Inference Using Exported Cases.
000219 (2020)	Sufang Tian [République populaire de Chine] ; Weidong Hu [République populaire de Chine] ; Li Niu [République populaire de Chine] ; Huan Liu [République populaire de Chine] ; Haibo Xu [République populaire de Chine] ; Shu-Yuan Xiao [États-Unis]	Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer.
000235 (2020)	Syed Faraz Ahmed [République populaire de Chine] ; Ahmed A. Quadeer [République populaire de Chine] ; Matthew R. Mckay [République populaire de Chine]	Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.
000238 (2020)	Helen C. Johnson ; Céline M. Gossner ; Edoardo Colzani [Suède] ; John Kinsman [Suède] ; Leonidas Alexakis [Suède] ; Julien Beauté [Suède] ; Andrea Würz [Suède] ; Svetla Tsolova [Suède] ; Nick Bundle [Suède] ; Karl Ekdahl [Suède]	Potential scenarios for the progression of a COVID-19 epidemic in the European Union and the European Economic Area, March 2020.
000242 (2020)	Zhong Sun [Malaisie] ; Karuppiah Thilakavathy [Malaisie] ; S Suresh Kumar [Malaisie] ; Guozhong He [République populaire de Chine] ; Shi V. Liu [États-Unis]	Potential Factors Influencing Repeated SARS Outbreaks in China.
000272 (2020)	Lisa M. Koonin	Novel coronavirus disease (COVID-19) outbreak: Now is the time to refresh pandemic plans.
000298 (2020)	Ling Xu [République populaire de Chine] ; Jia Liu [République populaire de Chine] ; Mengji Lu [Allemagne] ; Dongliang Yang [République populaire de Chine] ; Xin Zheng [République populaire de Chine]	Liver injury during highly pathogenic human coronavirus infections.
000315 (2020)	Hossam M. Ashour [États-Unis] ; Walid F. Elkhatib [Égypte] ; Md Masudur Rahman [Bangladesh] ; Hatem A. Elshabrawy [États-Unis]	Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks.
000325 (2020)	Eakachai Prompetchara [Thaïlande] ; Chutitorn Ketloy [Thaïlande] ; Tanapat Palaga [Thaïlande]	Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.
000462 (2020)	Sonja A. Rasmussen [États-Unis] ; John C. Smulian [États-Unis] ; John A. Lednicky [États-Unis] ; Tony S. Wen [États-Unis] ; Denise J. Jamieson [États-Unis]	Coronavirus Disease 2019 (COVID-19) and Pregnancy: What obstetricians need to know.
000470 (2020)	Miguel Angel Martinez [Espagne]	Compounds with therapeutic potential against novel respiratory 2019 coronavirus.
000517 (2020)	Hui Luo [République populaire de Chine] ; Qiao-Ling Tang [République populaire de Chine] ; Ya-Xi Shang [République populaire de Chine] ; Shi-Bing Liang [République populaire de Chine] ; Ming Yang [République populaire de Chine] ; Nicola Robinson [République populaire de Chine] ; Jian-Ping Liu [République populaire de Chine]	Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "provide" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "provide" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    provide
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Fri Mar 27 18:14:15 2020. Site generation: Sun Jan 31 15:15:08 2021